Reviewed against publicly available regulatory and manufacturer information. Last source review: July 21, 2026.
Upper-Face Concern Routing Table
| What the client says | What to assess first | What it means for the clinic |
|---|---|---|
| “I have horizontal lines when I raise my eyebrows.” | Whether frontalis activity is producing dynamic lines | Route this to the neuromodulator category rather than treating it as missing volume. Check the exact toxin product and its local indication. |
| “The lines between my eyebrows look deep.” | Dynamic glabellar lines versus a static tissue change | Evaluate the movement-related neuromodulator pathway separately and verify the chosen product’s documented role in the destination market. |
| “My temples look hollow.” | Whether the actual site is the temple rather than the forehead | Treat the temple as a distinct anatomical and documentation pathway. Review only an exact SKU with current temple-specific material for that market. |
| “My forehead looks hollow or uneven.” | Whether this is truly a forehead volume or contour concern | Do not turn the description into an automatic product shortlist. It requires individual clinical assessment and exact local product-and-site review. |
| “My eyebrows look lower and my forehead feels loose.” | Muscle activity, brow position, skin laxity, or a structural concern | This is not a simple filler-purchasing question. The clinic must identify the contributing problem before selecting any product category. |
| “I want a fuller forehead.” | Whether the expectation, exact site, local rules, and evidence can align | The request alone is not a product indication. Document the desired visual change, clinical assessment, destination market, and exact evidence before procurement review. |
Route the concern first, then enter the correct product category. Do not turn every upper-face concern into a forehead filler demand.

Clients often use one familiar word for several different observations. “Forehead filler” may mean horizontal lines that appear only with eyebrow movement, a crease between the eyebrows, a hollow at the temple, an uneven contour visible at rest, or a wish for a different brow position. Those descriptions do not lead to the same consultation or inventory decision.
The clinic’s useful output is therefore a routing note, not a brand ranking. The note should identify the client’s own description, the visible pattern at rest and during movement, the exact anatomical region, the relevant product category, and the documentation that must be checked before a product is discussed.
Why Routing Must Come Before Product Selection
A product-first consultation creates two avoidable errors. First, it can treat movement as if it were a volume deficit. Second, it can transfer evidence from one anatomical area to another because both areas are casually described as the “upper face.” A temple document, for example, does not automatically answer a forehead question.
Routing changes the order of work. The clinic begins with the concern and observable pattern, assigns the correct anatomical and product-category pathway, and then checks the exact SKU and destination-market material. Pack size, stock depth, or price only becomes relevant after those earlier decisions align.
This approach also makes the service menu easier to explain. A client who describes horizontal lines when raising the brows receives a movement-related assessment. A client pointing to the lateral hollow beside the forehead enters a temple pathway. A client describing central contour at rest stays in an individual forehead-contour assessment without being converted into a universal product recommendation.
Path 1: Movement-Related Forehead and Glabellar Lines
The fastest routing observation is whether the concern changes when the client raises the eyebrows or frowns. Horizontal lines associated with frontalis activity and glabellar lines associated with brow-depressor activity belong to a movement-related assessment, not automatically to a volume-restoration menu.
Current US prescribing information for BOTOX Cosmetic documents separate roles for moderate to severe forehead lines associated with frontalis activity and glabellar lines associated with corrugator or procerus activity in adults. That is evidence for one named product and its labeled uses; it is not permission to treat every neuromodulator brand, unit system, market, or patient as interchangeable.
For procurement, the clinic should record which line pattern is being addressed, the exact neuromodulator product, its current local authorization, the practitioner’s scope, and the intended service-menu wording. The filler catalogue should not be the first screen opened for a concern that appears mainly during movement.
Path 2: Temple Hollowing Is a Separate Site
Clients may point to the side of the upper face and call the whole area the forehead. The clinic should confirm whether the visible hollow is actually temporal rather than central frontal contour. That distinction changes the anatomical documentation and the product evidence that must be reviewed.
A temple pathway is still product specific. The presence of a temple-related document for one exact SKU cannot be transferred to a different filler, and a cheek or generalized facial-volume role does not become temple documentation by analogy. The clinic should check the full product name, presentation, manufacturer material, destination market, and current instructions before the SKU enters the consultation menu.
This routing is commercially useful because it sends a genuine temple concern to the appropriate content and inventory review instead of leaving it trapped inside a generic forehead filler question.
Path 3: When the Concern Is Truly Forehead Contour or Fullness
If the contour difference is visible at rest and is located in the forehead rather than the temple, the concern remains in the forehead pathway. That does not mean the next step is to choose a product from a generic dermal-filler list. The clinic still needs an individual clinical assessment of the visible contour, tissue, brow position, movement pattern, prior procedures, expectations, and the exact proposed site.
The procurement team should then ask a narrower question: does the exact SKU have current documentation that supports the proposed product, site, and destination market? If that evidence is absent or does not align, pack format and price cannot repair the gap. The article therefore does not create a universal forehead filler shortlist.
Expectation is part of the routing record. “Fuller,” “smoother,” “rounder,” “more even,” and “higher brow” describe different visual goals. Writing down the requested change helps prevent a clinic from promising that added volume will reproduce a movement-related, lifting, or skin-tightening result.
What Duration, Cost, and Photos Can Actually Tell a Clinic
Table of Contents
ToggleDuration follows the exact product-and-site pathway
A duration number is useful only after the clinic has identified the exact product, treatment site, and supporting evidence. A result range reported for the cheek, chin, fold, or temple should not be copied into a forehead consultation merely because the material belongs to the same broad filler family. If no exact evidence is available, the honest procurement conclusion is “duration not established for this planned pathway,” not a borrowed number.
Cost belongs after routing
Cost depends on the clinic, country, assessment, selected category, exact product, pack format, and treatment plan. Quoting a generic forehead filler price before routing can encourage the clinic or client to compare products for the wrong problem. The service menu should first name the concern pathway and only then connect it with product and pricing information that actually applies.
Photos should help classify the concern
Before-and-after images are most useful when they show what was assessed. For upper-face routing, a clinic may need standardized views at rest, with maximum eyebrow elevation, while frowning, and from an angle that separates the temple from the central forehead. The record should also state the follow-up time and whether another upper-face region was treated.
A single smooth-looking photograph cannot reveal whether the change came from movement control, volume, lighting, expression, swelling, retouching, or treatment of an adjacent region. Images can support classification and documentation; they do not replace the exact product-and-site evidence.
Clinic Workflow: From Client Phrase to Inventory Review
- Capture the client’s own words. Record whether the person says lines, hollowing, unevenness, fullness, brow descent, or laxity instead of translating every phrase into “forehead filler.”
- Observe rest and movement. Note whether the concern appears at rest, with eyebrow elevation, with frowning, or in more than one state.
- Name the exact region. Separate the central forehead, glabella, temple, brow, and adjacent areas rather than using “upper face” as the final site label.
- Assign the concern pathway. Choose movement-related lines, temple hollowing, true forehead contour or fullness, or a broader brow/skin/structural assessment.
- Select the product category only after routing. A neuromodulator pathway and a volume pathway require different evidence, and neither category creates a recommendation for every product within it.
- Check the exact product and market. Review the full product name, SKU, presentation, current manufacturer or regulatory material, destination-market authorization, and practitioner scope.
- Build inventory around documented services. Only after the earlier checks align should the clinic compare pack format, traceability, storage, ordering quantities, and replenishment needs.
FillersFairy is a distributor and sourcing channel. It can provide current sales presentation and supply documentation, while the clinic remains responsible for the individual assessment, intended site, professional scope, and destination-market requirements.
Frequently Asked Questions
What does forehead filler do?
Forehead filler is intended to add soft-tissue volume or change contour. It does not reduce muscle activity, tighten skin, or determine that filler is the correct category for every upper-face concern.
What pathway fits horizontal forehead lines that appear when the eyebrows rise?
First assess whether frontalis activity is producing dynamic lines. If it is, the concern belongs to a neuromodulator-category review, followed by verification of the exact product, current local indication, and individual clinical suitability.
Are glabellar lines the same problem as forehead hollowing?
No. Glabellar lines sit between the eyebrows and may be movement related, while forehead hollowing describes a contour or volume observation. The clinic should classify the pattern before reviewing a product category.
Is temple hollowing the same as a forehead contour concern?
No. The temple is an adjacent but distinct anatomical region. A true temple concern should be routed to an exact SKU and documentation review that specifically applies to the temple and destination market.
Is forehead filler approved in the United States?
No. The FDA lists injection into the forehead and glabella among unapproved dermal-filler uses and recommends against injecting dermal fillers into those areas. Approval or documentation for another facial site does not transfer to the forehead.
Choose the Next Guide by Concern
| Routing result | Next step inside FillersFairy |
|---|---|
| The concern appears movement related | Read the Forehead Lines and Botulinum Toxin Guide, then verify the exact product and local indication. |
| The concern is actually temple hollowing | Continue to the Temple Hollowing Guide and check whether the exact SKU documentation fits the destination market. |
| The concern remains true forehead contour or fullness | Complete the clinical and destination-market review first. If the lawful product category is then clear, request current pack and traceability documents from FillersFairy. |





